Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial
Details
Publication Year 2024-12,Volume 86,Issue #6,Page 595-596
Journal Title
European Urology
Publication Type
Commentary
Publisher
Elsevier
Department(s)
Surgical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-01-07 06:20:56
Last Modified: 2025-01-07 06:21:10

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙